The global single-cell multi-omics market is majorly influenced by the increasing disease burden globally. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial.
The global single-cell multi-omics market was valued at $1,221.5 million in 2020 and is anticipated to grow to $3,188.9 million by the end of 2025, growing at a projected CAGR of 21.16% during the forecast period 2020-2025. The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development.
The global single-cell multi-omics market is majorly influenced by the increasing disease burden globally. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial.
The global single-cell multi-omics market was valued at $1,221.5 million in 2020 and is anticipated to grow to $3,188.9 million by the end of 2025, growing at a projected CAGR of 21.16% during the forecast period 2020-2025. The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development.